[Skip to content]

.

GOSH surgeon wins award for hip research

5 April 2011

Mr Andreas Roposch, orthopaedic surgeon, has won the 2010 best clinical research award from the European Paediatric Orthopaedic Society for his work on newborn hip dysplasia. The Society is one of the two largest professional societies for children’s orthopaedics in the world.  The research, across 32 countries, started from the knowledge that there is wide variation in the reported prevalence of hip dysplasia and that treatment for hip dysplasia varies by surgeon, centre and country.

Mr Roposch comments, “It is unclear why there is such a wide variation in prevalence rates but it could either be that there are intrinsic differences in the population studied, or that clinicians use variable criteria when making the diagnosis of hip dysplasia. The process of diagnosis is fundamental to clinical medicine. If we don’t get the diagnosis right, variations in care are inevitable. The lack of uniform, widely agreed on diagnostic criteria in this age group has the potential for late diagnoses.” 

The confused state of diagnosis can be shown in their study of clinicians which found over 200 diagnostic criteria for hip dysplasia used in infants under two months old.  In their research, the team established international consensus about the most important diagnostic criteria for hip dysplasia and reduced these from 200 to 37 criteria, which will be subject to further investigation. The ultimate goal is to develop, from basic principals, a set of standardized diagnostic criteria that is a model of expert clinicians’ practice. Once validated such criteria will enable other health care providers to establish the diagnosis of hip dysplasia in a manner approaching that of clinical experts. 

Mr Roposch added “This research was initially funded by a Pump Prime Award from the GOS Charity in 2006 but due to its success we were able to secure external funding [Bupa Foundation]. It shows how successful GOS Charity Funding can turn out to be and how important internal funding schemes are to get new research ideas started.”

Hip dysplasia benefits from early diagnosis and treatment.  Oonagh Keith, mother of Siomha, treated at Great Ormond Street said “If caught early, [hip dysplasia] is one of those disabilities that doesn’t have to be a disability.”

GOS is a main referral centre for hip dysplasia, particularly for late diagnosed patients. Links exist with the UCLH maternity service  and academically with ICH. Children seen at or admitted to GOS for late diagnosed hip dysplasia have a significant higher risk for unfavourable outcomes including impaired physical functioning. Improved diagnosis therefore has the potential to reduce such outcomes.

http://www.dailymail.co.uk/health/article-1231214/Mother-launches-campaign-hip-test-babies-banish-agonising-disability.html

Contact information:

GOSH-ICH Press Office: 020 7239 3125
Email: Coxs@gosh.nhs.uk
For genuine and urgent out of hours call speak to switchboard on 020 7405 9200

Notes to editors

Great Ormond Street Hospital for Children NHS Trust is the country’s leading centre for treating sick children, with the widest range of specialists under one roof.

With the UCL Institute of Child Health, we are the largest centre for paediatric research outside the US and play a key role in training children’s health specialists for the future.

Our charity needs to raise £50 million every year to help rebuild and refurbish Great Ormond Street Hospital, buy vital equipment and fund pioneering research. With your help we provide world class care to our very ill children and their families.